financetom
Business
financetom
/
Business
/
Minerals Technologies Q4 Earnings Up, Revenue Falls -- Shares Up After Hours
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Minerals Technologies Q4 Earnings Up, Revenue Falls -- Shares Up After Hours
Feb 6, 2025 2:54 PM

05:34 PM EST, 02/06/2025 (MT Newswires) -- Minerals Technologies ( MTX ) reported Q4 diluted earnings Thursday of $1.68 per share, up from $1.22 a year earlier.

Two analysts polled by FactSet expected $1.41.

Revenue for the quarter ended Dec. 31 was $518.1 million, down from $524.5 million a year earlier.

Analysts surveyed by FactSet expected $523 million.

Shares were up 5% in after-hours activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Ultragenyx Pharmaceutical Begins Biologics License Application for Glycogen Storage Disease Gene Therapy
Ultragenyx Pharmaceutical Begins Biologics License Application for Glycogen Storage Disease Gene Therapy
Aug 18, 2025
08:23 AM EDT, 08/18/2025 (MT Newswires) -- Ultragenyx Pharmaceutical ( RARE ) said Monday it initiated a rolling submission of a biologics license application for its DTX401 AAV gene therapy as treatment for glycogen storage disease Type Ia with the US Food and Drug Administration. The company said it aims to complete the full application, including submission of the chemistry,...
Bayer settles Sky Valley cases over chemical PCB
Bayer settles Sky Valley cases over chemical PCB
Aug 18, 2025
Aug 18 (Reuters) - Bayer said on Monday its Monsanto unit reached agreements in principle with more than 200 plaintiffs to resolve the so-called Sky Valley Education Center product liability cases related to the chemical PCB. Bayer said in its statement that the terms of the agreements over environmental pollution with PCB, short for polychlorinated biphenyls, were confidential and subject...
Catheter Precision Receives UK Approval for Suture Retention Device
Catheter Precision Receives UK Approval for Suture Retention Device
Aug 18, 2025
08:24 AM EDT, 08/18/2025 (MT Newswires) -- Catheter Precision ( VTAK ) said Monday that it has received registration and approval in the UK for its LockeT suture retention device, allowing it to launch sales in the nation. Catheter Precision ( VTAK ) said it has entered into an agreement with UK-based HC21 to distribute LockeT. LockeT received a CE...
Plus Therapeutics Says Data Shows Reyobiq in Leptomeningeal Metastases Has Promising Efficacy Signal
Plus Therapeutics Says Data Shows Reyobiq in Leptomeningeal Metastases Has Promising Efficacy Signal
Aug 18, 2025
08:22 AM EDT, 08/18/2025 (MT Newswires) -- Plus Therapeutics ( PSTV ) said Monday that data from an early-stage trial using Reyobiq to treat leptomeningeal metastases, a kind of cancer, is feasible, has a manageable safety profile, and shows a promising efficacy signal. The study involved 29 patients in six cohorts who received a different dosage in each one, the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved